I dag er slankemidlet Wegovy p alles lber, og historien om GLP1 som et mirakelmiddel til behandling af alverdens sygdomme er langt fra slut, spr Jens Juul Holst
A few GLP-1 agonists currently in phase 3 trials are higher-dose injectable semaglutide 7.2 mg (Novo Nordisk), oral semaglutide 50 mg (Novo Nordisk) and orforglipron (Eli Lilly)
Key Differences Celtuide Contains semaglutide , a GLP-1 receptor agonist Administered once weekly using a prefilled injection pen Administered once weekly using a prefilled injection pen Trulicity Contains dulaglutide , another GLP-1 receptor agonist Also administered once weekly Designed to help control blood glucose levels in adults with type 2 diabetes Celtuide vs Bydureon Celtuide and Bydureon are injectable medications used to help manage blood glucose levels in adults with type 2 diabetes
Tronieri reports receiving an investigator-initiated grant, on behalf of the University of Pennsylvania, from Novo Nordisk and receiving consulting fees from Currax Pharmaceuticals, LLC
SmPC last updated 26 February 2026)Tier 1 primary [2]EMA CHMP meeting highlights (8-11 December 2025): positive opinion to extend Mounjaro (tirzepatide) to type-2 diabetes in adolescents and children aged 10 and overTier 1 primary [3]SURPASS-2: Frias JP et al., Tirzepatide versus semaglutide once weekly in patients with type-2 diabetes (NEJM, 2021
Ideal Candidates All candidates interested in tirzepatide should be in good overall health and free from any underlying conditions that may impact the effectiveness of the medication
